Health Catalyst, Inc. (HCAT)

Over the past six months, Health Catalyst's stock price has experienced a significant decline. Key events impacting the stock include the Q4 and Full Year 2025 Earnings Report, which reported mixed results and led to a stock plunge. Ben Albert was appointed as the new Chief Executive Officer, accelerating the CEO succession. The new CEO initiated a strategic review to evaluate the firm's cost structure, product portfolio, and investment mix. Wells Fargo downgraded the stock, citing structural concerns, and Cantor Fitzgerald flagged ongoing Ignite transition pressures. Health Catalyst reported strong financial performance for Q3 2025, exceeding guidance for total revenue and Adjusted EBITDA.

While specific detailed information on demand seasonality for Health Catalyst's products and services is not explicitly provided, some insights can be inferred. A Seeking Alpha article from June 2025 noted that Q1 is typically a softer quarter for HCAT compared to the rest of the year in terms of bookings momentum. The ongoing shift in the healthcare industry towards value-based care and the increasing reliance on data-driven outcomes suggest a generally stable and growing demand for healthcare analytics and technology solutions. However, the "Ignite" platform transition has been cited as a source of "migration challenges" and "ongoing transition pressures" that could impact revenue and margins.

Health Catalyst, Inc. is a healthcare data and analytics technology company providing data and analytics technology and services to healthcare organizations. Its core offering is the cloud-based Health Catalyst Ignite™ ecosystem, which includes a data platform, AI-enabled analytics software, and professional services expertise. The platform helps healthcare organizations integrate and organize data from various disparate systems into a single analytics environment. In addition to its technology platform, Health Catalyst provides a range of professional services to help health systems and hospitals adopt data-driven practices, improve clinical quality, and reduce costs. Health Catalyst serves a diverse client base, including academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, and life science organizations.

Health Catalyst serves over 1,200 healthcare organizations worldwide, primarily across the United States, with expansion into select international markets. Its corporate office is located in South Jordan, Utah, United States.

Health Catalyst's brand reputation has been influenced by both positive developments and challenges. The company has been recognized for its cloud-based technology ecosystem, Health Catalyst Ignite™, and its AI-enabled data and analytics solutions. However, the company's reputation has also faced scrutiny due to its financial performance and strategic transitions. Analysts have also expressed a "Hold" consensus rating, with some downgrades citing structural concerns and pressures related to the Ignite transition.

Health Catalyst, Inc. has a significant institutional ownership presence, with 141 institutional owners and shareholders holding a total of 55,900,695 shares. The largest individual shareholder is Mathew Paul Arens, owning 11.03 million shares, representing 14.99% of the company. Individual insiders also maintain a notable presence within the ownership structure.